Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Combined Surgery

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT06830070Active Not RecruitingPrimary

Subjective Pain Scoring for Subtenonal Anesthesia During Vitrectomy

NCT02406430CompletedPrimary

Prognostic Factors in Epiretinal Membrane Surgery

NCT00537992Not ApplicableCompletedPrimary

Blue-Blocking IOLs in Combined Surgery

Showing all 3 trials

Research Network

Common Treatments

  • Combined Surgery1
  • A Combined Cataract And Erm Surgery1
  • Subjective Pain Score Assessment1

Active Sponsors

  • Centre Hospitalier Universitaire Dijon1
  • Prim. Prof. Dr. Oliver Findl, MBA1
  • The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery1

Top Investigators

Related Conditions

  • Cataract1
  • Macular Holes1
  • Full Thickness Macular Hole1
  • Retinal Detachment1

Activity Timeline